8. Results of glycemic control with Insulin infusion among severe stroke patients
Main Article Content
Abstract
Achieving glycemic control is related partially to the outcomes in stroke patients. We conducted an interventional study on severe stroke patients admitted to the Can Tho Central General Hospital. Insulin infusion was used to control blood glucose levels in nine-teen patients with persistent hyperglycemia according to the Cleveland intensive care unit protocol, and we evaluated the glycemic control. The median blood glucose concentration achieved before and after insulin infusion on glycemic control was 281 mg/dL (IQR: 231 - 317) and 168 mg/dL (IQR: 156 - 175), respectively, with minimizing glycemic fluctuation. The target blood level was reached by 78.9% of patients, and one patient had hypoglycemia. The proportion of non-survivors was 63.2%. Despite achieving the target blood glucose level, most patients experienced low hypoglycemia when using this protocol. Nevertheless, patients who suffered a severe stroke had a relatively high mortality.
Article Details
Keywords
Severe stroke; insulin infusion; hyperglycemia
References
2. Ton DM, Co XD, Khue NL. Current State of Stroke Care in Vietnam. Stroke Vasc Interv Neurol. 2022; 2(2) :1-5. doi: 10.1161/SVIN.121.000331.
3. Kirkman MA, Citerio G, Smith M. The intensive care management of acute ischemic stroke: an overview. Intensive Care Med. 2014; 40(5): 640-53. doi: 10.1007/s00134-014-3266-z.
4. Zhao XJ, Li QX, Chang LS et al. Evaluation of the Application of APACHE II Combined With NIHSS Score in the Short-Term Prognosis of Acute Cerebral Hemorrhage Patient. Front Neurol. 2019; 10: 475. doi: 10.3389/fneur.2019.00475.
5. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001; 32 (10): 2426-32. doi: 10.1161/hs1001.096194.
6. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001; 17 (1): 107-24. doi: 10.1016/s0749-0704(05)70154-8.
7. Snarska KK, Bachórzewska-Gajewska H, Kapica-Topczewska K et al. Hyperglycemia and diabetes have different impacts on outcome of ischemic and hemorrhagic stroke. Arch Med Sci. 2017; 13 (1): 100-108. doi: 10.5114/aoms.2016.61009.
8. Wu TY, Putaala J, Sharma G et al. Persistent Hyperglycemia Is Associated With Increased Mortality After Intracerebral Hemorrhage. J Am Heart Assoc. 2017; 6 (8): e005760. doi: 10.1161/JAHA.117.005760.
9. American Diabetes Association Professional Practice Committee. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022; 45 (1): 244-253. doi: 10.2337/dc22-S016.
10. Sacco RL, Kasner SE, Broderick JP et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44 (7): 2064-89. doi: 10.1161/STR.0b013e318296aeca.
11. Gibson GA, Militello MA, Guzman JA, et al. Evaluation of an updated insulin infusion protocol at a large academic medical center. Am J Health Syst Pharm. 2016;73(11):88-93. doi: 10.2146/ajhp150383
12. Badawi O, Yeung SY, Rosenfeld BA. Evaluation of glycemic control metrics for intensive care unit populations. Am J Med Qual. 2009; 24 (4): 310-20. doi: 10.1177/1062860609336366.
13. Brunner R, Adelsmayr G, Herkner H et al. Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data. Crit Care. 2012; 16: 1-9. doi: 10.1186/cc11657.
14. Fuentes B, Ntaios G, Putaala J et al. European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. Eur Stroke J. 2018; 3 (1): 5-21. doi: 10.1016/j.clnu.2018.08.037.
15. Krinsley JS, Chase JG, Gunst J et al. Continuous glucose monitoring in the ICU: clinical considerations and consensus. Crit Care. 2017; 21 (1): 1-8. doi: 10.1186/s13054-017-1784-0.
16. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360 (13): 1283-97. doi: 10.1056/NEJMoa0810625.